Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy ...

The BioMed X Institute has launched a new global call for research proposals in collaboration with Boehringer Ingelheim.

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Hot on the heels of a $150 million fundraise, Atsena Therapeutics is back with early-stage data for the company’s eye disease ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Biomedical engineers at Duke University have developed a novel imaging system that harnesses the power of artificial ...

New research reveals a retinal light test may hold the key to detecting Parkinson's disease long before motor symptoms appear ...

A density gradient of basement membrane laminins modulates retinal pigment epithelium contractility levels by differential ...

Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biotechnology company developing gene therapies for the treatment of ...

Researchers in South Korea claimed to have developed a drug with the ability to reverse retinal damage and restore vision. A ...

Background Coronary artery disease (CAD) is linked to an increased risk of mild cognitive impairment (MCI). Effective and ...